Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Attentional bias to cannabis cues in cannabis users but not cocaine users.

Alcorn JL 3rd, Marks KR, Stoops WW, Rush CR, Lile JA.

Addict Behav. 2019 Jan;88:129-136. doi: 10.1016/j.addbeh.2018.08.023. Epub 2018 Aug 23.

PMID:
30176501
2.

Contribution of cocaine-related cues to concurrent monetary choice in humans.

Strickland JC, Marks KR, Beckmann JS, Lile JA, Rush CR, Stoops WW.

Psychopharmacology (Berl). 2018 Oct;235(10):2871-2881. doi: 10.1007/s00213-018-4978-5. Epub 2018 Jul 26.

PMID:
30046863
3.

Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users.

Wesley MJ, Westgate PM, Stoops WW, Kelly TH, Hays LR, Lile JA.

Exp Clin Psychopharmacol. 2018 Jun;26(3):310-319. doi: 10.1037/pha0000180.

PMID:
29863387
4.

Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.

Reynolds AR, Strickland JC, Stoops WW, Lile JA, Rush CR.

Drug Alcohol Depend. 2017 Dec 1;181:25-29. doi: 10.1016/j.drugalcdep.2017.08.038. Epub 2017 Sep 22.

5.

N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order.

Levi Bolin B, Alcorn JL 3rd, Lile JA, Rush CR, Rayapati AO, Hays LR, Stoops WW.

Drug Alcohol Depend. 2017 Sep 1;178:452-460. doi: 10.1016/j.drugalcdep.2017.05.039. Epub 2017 Jun 29.

6.

A Prototypical First-Generation Electronic Cigarette Does Not Reduce Reports of Tobacco Urges or Withdrawal Symptoms among Cigarette Smokers.

Harvanko AM, Martin CA, Kryscio RJ, Stoops WW, Lile JA, Kelly TH.

J Addict. 2017;2017:6748948. doi: 10.1155/2017/6748948. Epub 2017 Mar 26.

7.

Neurophysiological capacity in a working memory task differentiates dependent from nondependent heavy drinkers and controls.

Wesley MJ, Lile JA, Fillmore MT, Porrino LJ.

Drug Alcohol Depend. 2017 Jun 1;175:24-35. doi: 10.1016/j.drugalcdep.2017.01.029. Epub 2017 Mar 21.

8.

Unique prediction of cannabis use severity and behaviors by delay discounting and behavioral economic demand.

Strickland JC, Lile JA, Stoops WW.

Behav Processes. 2017 Jul;140:33-40. doi: 10.1016/j.beproc.2017.03.017. Epub 2017 Mar 24.

9.

A pilot investigation of acute inhibitory control training in cocaine users.

Alcorn JL 3rd, Pike E, Stoops WS, Lile JA, Rush CR.

Drug Alcohol Depend. 2017 May 1;174:145-149. doi: 10.1016/j.drugalcdep.2017.01.014. Epub 2017 Feb 28.

10.

Comparing exponential and exponentiated models of drug demand in cocaine users.

Strickland JC, Lile JA, Rush CR, Stoops WW.

Exp Clin Psychopharmacol. 2016 Dec;24(6):447-455.

11.

Human drug discrimination: A primer and methodological review.

Bolin BL, Alcorn JL, Reynolds AR, Lile JA, Rush CR.

Exp Clin Psychopharmacol. 2016 Aug;24(4):214-28. doi: 10.1037/pha0000077. Review.

12.

Differential sensitivity to learning from positive and negative outcomes in cocaine users.

Strickland JC, Bolin BL, Lile JA, Rush CR, Stoops WW.

Drug Alcohol Depend. 2016 Sep 1;166:61-8. doi: 10.1016/j.drugalcdep.2016.06.022. Epub 2016 Jun 27.

13.

Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.

Bolin BL, Alcorn JL, Reynolds AR, Lile JA, Stoops WW, Rush CR.

Curr Top Behav Neurosci. 2018;39:261-295. doi: 10.1007/7854_2016_10. Review.

14.

Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans.

Lile JA, Stoops WW, Rush CR, Negus SS, Glaser PE, Hatton KW, Hays LR.

Drug Alcohol Depend. 2016 Aug 1;165:111-9. doi: 10.1016/j.drugalcdep.2016.05.022. Epub 2016 May 28.

15.

Development of a translational model to screen medications for cocaine use disorder I: Choice between cocaine and food in rhesus monkeys.

Johnson AR, Banks ML, Blough BE, Lile JA, Nicholson KL, Negus SS.

Drug Alcohol Depend. 2016 Aug 1;165:103-10. doi: 10.1016/j.drugalcdep.2016.05.021. Epub 2016 May 28.

16.

Buspirone reduces sexual risk-taking intent but not cocaine self-administration.

Bolin BL, Lile JA, Marks KR, Beckmann JS, Rush CR, Stoops WW.

Exp Clin Psychopharmacol. 2016 Jun;24(3):162-73. doi: 10.1037/pha0000076.

17.

Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.

Marks KR, Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR.

J Clin Psychopharmacol. 2016 Jun;36(3):213-21. doi: 10.1097/JCP.0000000000000488.

18.

Safety and tolerability of intranasal cocaine during phendimetrazine maintenance.

Stoops WW, Strickland JC, Hays LR, Rayapati AO, Lile JA, Rush CR.

Psychopharmacology (Berl). 2016 Jun;233(11):2055-2063. doi: 10.1007/s00213-016-4260-7. Epub 2016 Mar 1.

19.

Sex differences in the subjective effects of oral Δ9-THC in cannabis users.

Fogel JS, Kelly TH, Westgate PM, Lile JA.

Pharmacol Biochem Behav. 2017 Jan;152:44-51. doi: 10.1016/j.pbb.2016.01.007. Epub 2016 Jan 15.

20.

Abnormal medial prefrontal cortex activity in heavy cannabis users during conscious emotional evaluation.

Wesley MJ, Lile JA, Hanlon CA, Porrino LJ.

Psychopharmacology (Berl). 2016 Mar;233(6):1035-44. doi: 10.1007/s00213-015-4180-y. Epub 2015 Dec 22.

21.

Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.

Lile JA, Wesley MJ, Kelly TH, Hays LR.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):215-24. doi: 10.1097/FBP.0000000000000187.

22.

Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedules.

Strickland JC, Lile JA, Rush CR, Stoops WW.

Hum Psychopharmacol. 2014 Jul;29(4):342-50. doi: 10.1002/hup.2409. Epub 2014 May 19.

23.

Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2014 Oct 1;143:141-8. doi: 10.1016/j.drugalcdep.2014.07.016. Epub 2014 Jul 29.

24.

Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users.

Marks KR, Lile JA, Stoops WW, Rush CR.

Psychopharmacology (Berl). 2014 Jul;231(14):2741-50. doi: 10.1007/s00213-014-3449-x. Epub 2014 Jan 25.

25.

Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans.

Stoops WW, Bennett JA, Lile JA, Sevak RJ, Rush CR.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:111-7. doi: 10.1016/j.pnpbp.2013.08.007. Epub 2013 Aug 28.

26.

The relative reinforcing strength of methamphetamine and D-amphetamine in monkeys self-administering cocaine.

Lile JA, Charnigo RJ, Nader MA.

Behav Pharmacol. 2013 Sep;24(5-6):482-5. doi: 10.1097/FBP.0b013e3283644d44.

27.

Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Δ(9) -THC in cannabis users.

Lile JA, Kelly TH, Charnigo RJ, Stinchcomb AL, Hays LR.

J Clin Pharmacol. 2013 Jul;53(7):680-90. doi: 10.1002/jcph.90. Epub 2013 Jun 10.

28.

Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):216-23. doi: 10.1016/j.drugalcdep.2012.05.023. Epub 2012 Jun 13.

29.

Influence of acute bupropion pre-treatment on the effects of intranasal cocaine.

Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR.

Addiction. 2012 Jun;107(6):1140-7. doi: 10.1111/j.1360-0443.2011.03766.x. Epub 2012 Feb 11.

30.

Alternative reinforcer response cost impacts cocaine choice in humans.

Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):189-93. doi: 10.1016/j.pnpbp.2011.10.003. Epub 2011 Oct 12.

31.

Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2012 Apr 1;122(1-2):61-9. doi: 10.1016/j.drugalcdep.2011.09.010. Epub 2011 Oct 4.

32.

Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women.

Babalonis S, Lile JA, Martin CA, Kelly TH.

Behav Pharmacol. 2011 Sep;22(5-6):441-9. doi: 10.1097/FBP.0b013e328349fc02.

33.

Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance.

Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR.

Pharmacol Biochem Behav. 2011 Nov;100(1):40-7. doi: 10.1016/j.pbb.2011.06.024. Epub 2011 Jul 23.

34.

Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance.

Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR.

Drug Alcohol Depend. 2011 Dec 15;119(3):187-93. doi: 10.1016/j.drugalcdep.2011.06.006. Epub 2011 Jul 6.

35.

Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women.

Babalonis S, Lile JA, Martin CA, Kelly TH.

Psychopharmacology (Berl). 2011 Jun;215(3):429-39. doi: 10.1007/s00213-011-2206-7. Epub 2011 Feb 25.

36.

Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):86-92. doi: 10.1016/j.drugalcdep.2010.11.019. Epub 2011 Jan 11.

37.

Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance.

Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR.

Psychopharmacology (Berl). 2011 Apr;214(3):665-74. doi: 10.1007/s00213-010-2067-5. Epub 2010 Nov 12.

PMID:
21072503
38.

Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.

Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR.

J Psychopharmacol. 2011 Nov;25(11):1469-79. doi: 10.1177/0269881110385597. Epub 2010 Oct 15.

PMID:
20952456
39.

Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating δ9-tetrahydrocannabinol.

Lile JA, Kelly TH, Hays LR.

Clin Neuropharmacol. 2010 Sep-Oct;33(5):235-42. doi: 10.1097/WNF.0b013e3181e77428.

PMID:
20838217
40.

Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.

Lile JA, Babalonis S, Emurian C, Martin CA, Wermeling DP, Kelly TH.

J Clin Pharmacol. 2011 Jun;51(6):888-98. doi: 10.1177/0091270010375956. Epub 2010 Jul 29.

41.

Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans.

Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR.

Eur J Pharmacol. 2010 Oct 10;644(1-3):101-5. doi: 10.1016/j.ejphar.2010.06.055. Epub 2010 Jul 16.

42.

Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers.

Stoops WW, Lile JA, Rush CR.

Pharmacol Biochem Behav. 2010 Apr;95(2):187-91. doi: 10.1016/j.pbb.2010.01.003. Epub 2010 Jan 29.

43.
44.

Moving beyond the cannabis controversy into the world of the cannabinoids.

Budney AJ, Lile JA.

Int Rev Psychiatry. 2009 Apr;21(2):91-5. doi: 10.1080/09540260902782729. No abstract available.

PMID:
19367502
45.

Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.

Lile JA, Kelly TH, Pinsky DJ, Hays LR.

Psychopharmacology (Berl). 2009 Apr;203(2):241-50. doi: 10.1007/s00213-008-1393-3. Epub 2008 Nov 19.

46.
47.

Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women.

Babalonis S, Emurian CS, Martin CA, Lile JA, Kelly TH.

Drug Alcohol Depend. 2008 Apr 1;94(1-3):276-80. doi: 10.1016/j.drugalcdep.2007.11.007.

48.

The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.

Stoops WW, Lile JA, Lofwall MR, Rush CR.

Am J Drug Alcohol Abuse. 2007;33(6):769-76.

PMID:
17994473
49.

Similar discriminative-stimulus effects of D-amphetamine in women and men.

Vansickel AR, Lile JA, Stoops WW, Rush CR.

Pharmacol Biochem Behav. 2007 Jun-Jul;87(2):289-96. Epub 2007 May 13.

50.

Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.

Lile JA, Kendall SL, Babalonis S, Martin CA, Kelly TH.

Pharmacol Biochem Behav. 2007 Jun-Jul;87(2):258-66. Epub 2007 May 5.

Supplemental Content

Support Center